| Literature DB >> 33345090 |
Marta Camacho-Cardenosa1, Alba Camacho-Cardenosa1, Adrián González-Custodio1, Víctor Zapata1, Guillermo Olcina1.
Abstract
The aim of this study was to investigate the effect of a 4 weeks in-water swimming-specific repeated-sprint training in hypoxia (RSH) compared to similar training in normoxia (RSN). Following a repeated-measures, counterbalanced cross-over design, 10 swimmers were requested to perform two trials consisting of in-water repeated sprints in hypoxic (RSH, simulated 4,040 m; FiO2 = 13.7%) or normoxic (RSN, 459 m, FiO2 calibrated = 20.9%) conditions. In both conditions, 8 additional exercise including 3 sets of 5 × 15 m "all-out" sprints (corresponding to a total of 625 m), with 20 s of passive recovery between efforts and 200 m of easy swimming between sets were included at the end of their swimming program over a 4 weeks period. Hypoxic condition was generated using a simulator pumping air with lowered oxygen concentration into a facial mask. An incremental maximal test on an ergocycle, as well as 100 m and 400 m freestyle swimming performance (real competition format) were assessed before (pre), 7 days (post-1), and 2 weeks (post-2) after intervention. During training, heart rate (HR) and oxygen saturation (SpO2) were monitored. RSH showed significantly lower SpO2 (70.1 ± 4.8% vs. 96.1 ± 2.7%, P < 0.01), concomitant with higher mean HR (159 ± 11 bmp vs. 141 ± 6 bmp, P < 0.01) than RSN. No significant changes in maximal oxygen uptake, other submaximal physiological parameters, 100 or 400 m swimming performances were found. Although providing additional physiological stress, performing in-water RSH does not provide evidence for higher benefits than RSN to improve swimmers performance.Entities:
Keywords: altitude; hypoxemia; performance; repeated-sprint ability; water sports
Year: 2020 PMID: 33345090 PMCID: PMC7739721 DOI: 10.3389/fspor.2020.00100
Source DB: PubMed Journal: Front Sports Act Living ISSN: 2624-9367
Figure 1Time courses of changes in SpO2 and mean HR over the RSH/RSN intervention. Mean ± standard deviation. *P < 0.01 vs. RSN.
Figure 2Swimming 100 m (A) and 400 m (B) freestyle performance. Mean ± standard deviation before (pre), 7 days (post-1), and 2-weeks (post-2) after intervention.
Exercise testing maximal parameters before (pre), 7 days (post-1), and 2-weeks (post-2) after intervention.
| Lactate, Mmol | RSH | 9.0 ± 1.6 | 10.6 ± 4.0 | 17.8 | 0.57 | 11.9 ± 6.7 | 32.2 | 0.24 | 0.055 | 0.676 | 0.417 |
| RSN | 9.2 ± 1.5 | 9.7 ± 2.2 | 5.4 | 0.27 | 14.5 ± 4.0 | 57.6 | 1.55 | 0.007 | |||
| VO2max, L·min−1 | RSH | 2.9 ± 0.2 | 2.7 ± 0.4 | −6.9 | 0.67 | 2.6 ± 0.3 | −10.3 | 0.29 | 0.071 | 0.475 | 0.081 |
| RSN | 2.8 ± 0.2 | 2.5 ± 0.2 | −10.7 | 1.50 | 2.6 ± 0.2 | −7.1 | 0.50 | 0.012 | |||
| Absolute workload, watts | RSH | 198.0 ± 16.4 | 192.0 ± 16.4 | −3.0 | 0.37 | 192.0 ± 16.4 | −3.0 | 0.00 | 0.375 | 0.421 | 0.709 |
| RSN | 190.0 ± 15.5 | 180.0 ± 26.8 | −5.3 | 0.47 | 190.0 ± 15.5 | 0.0 | 0.47 | 0.432 | |||
| TtE, min | RSH | 15.6 ± 1.8 | 15.6 ± 2.0 | 0.0 | 0.00 | 15.2 ± 1.2 | −2.6 | 0.25 | 0.844 | 0.652 | 0.553 |
| RSN | 15.1 ± 1.8 | 14.6 ± 1.8 | −3.3 | 0.28 | 15.4 ± 1.9 | 2.0 | 0.43 | 0.822 | |||
| HRmax, beats·min−1 | RSH | 192.5 ± 3.1 | 182.7 ± 10.7 | −5.1 | 1.42 | 183.7 ± 9.3 | −4.6 | 0.10 | 0.068 | 0.754 | 0.735 |
| RSN | 193.5 ± 4.0 | 183.0 ± 4.9 | −5.4 | 2.36 | 186.3 ± 10.0 | −3.7 | 0.44 | 0.021 | |||
| RER | RSH | 1.19 ± 0.06 | 1.21 ± 0.08 | 1.7 | 0.29 | 1.20 ± 0.04 | 0.8 | 0.17 | 0.403 | 0.997 | 0.223 |
| RSN | 1.20 ± 0.05 | 1.17 ± 0.06 | −2.5 | 0.55 | 1.23 ± 0.06 | 2.5 | 1.00 | 0.354 | |||
Mean ± standard deviation; VO. *Indicates differences with respect to baseline (post-hoc t-test with Bonferroni correction):
P < 0.05,
P < 0.01,
P < 0.001.
Exercise testing anaerobic threshold parameters before (pre), 7 days (post-1), and 2-weeks (post-2) after intervention.
| VO2, L·min−1 | RSH | 2.3 ± 0.2 | 2.2 ± 0.3 | −4.3 | 0.40 | 2.1 ± 0.2 | −8.7 | 0.40 | 0.211 | 0.553 | 0.679 |
| RSN | 2.2 ± 0.2 | 2.0 ± 0.3 | −9.1 | 0.80 | 2.1 ± 0.3 | −4.5 | 0.33 | 0.225 | |||
| Absolute Workload, watts | RSH | 168.0 ± 16.4 | 168.0 ± 16.4 | 0.0 | 0.00 | 168.0 ± 16.4 | 0.0 | 0.00 | 0.906 | 0.517 | 0.903 |
| RSN | 160.0 ± 15.5 | 160.0 ± 24.5 | 0.0 | 0.00 | 165.0 ± 25.1 | 3.1 | 0.20 | 0.903 | |||
| Time, min | RSH | 12.3 ± 1.6 | 12.3 ± 1.6 | 0.0 | 0.00 | 12.30 ± 1.6 | 0.0 | 0.00 | 0.905 | 0.518 | 0.906 |
| RSN | 11.5 ± 1.5 | 11.5 ± 2.4 | 0.0 | 0.00 | 12.0 ± 2.5 | 4.3 | 0.20 | 0.903 | |||
| HRmax, beats·min−1 | RSH | 174.2 ± 8.8 | 173.5 ± 10.6 | −0.4 | 0.07 | 171.7 ± 12.2 | −1.4 | 0.16 | 0.656 | 0.790 | 0.816 |
| RSN | 173.7 ± 6.9 | 170.7 ± 5.6 | −1.7 | 0.48 | 171.3 ± 9.8 | −1.4 | 0.08 | 0.691 | |||
Mean ± standard deviation; VO.
Exercise testing aerobic threshold parameters before (pre), 7 days (post-1), and 2-weeks (post-2) after intervention.
| VO2, L·min−1 | RSH | 1.7 ± 0.1 | 1.6 ± 0.1 | −5.9 | 1.00 | 1.6 ± 0.1 | −5.9 | 0.00 | 0.023 | 0.485 | 0.539 |
| RSN | 1.7 ± 0.2 | 1.6 ± 0.1 | −5.9 | 0.67 | 1.6 ± 0.1 | −5.9 | 0.00 | 0.025 | |||
| Absolute Workload, watts | RSH | 120.0 ± 0.0 | 120.0 ± 0.0 | 0.0 | 0.00 | 120.0 ± 0.0 | 0.0 | 0.00 | 0.389 | 0.389 | 0.401 |
| RSN | 115.0 ± 12.2 | 115.0 ± 12.2 | 0.0 | 0.00 | 120.0 ± 0.0 | 4.3 | 0.82 | 0.401 | |||
| Time, min | RSH | 7.5 ± 0.0 | 7.5 ± 0.0 | 0.0 | 0.00 | 7.5 ± 0.0 | 0.0 | 0.00 | 0.388 | 0.388 | 0.389 |
| RSN | 7.0 ± 1.2 | 7.0 ± 1.2 | 0.0 | 0.00 | 7.5 ± 0.0 | 7.1 | 0.83 | 0.402 | |||
| HRmax, beats·min−1 | RSH | 150.2 ± 5.9 | 150.0 ± 8.0 | −0.1 | 0.03 | 148.5 ± 8.3 | −1.1 | 0.18 | 0.887 | 0.594 | 0.790 |
| RSN | 148.2 ± 8.0 | 146.7 ± 6.4 | −1.0 | 0.21 | 148.2 ± 4.7 | 0.0 | 0.27 | 0.918 | |||
Mean ± standard deviation; VO2 (absolute oxygen uptake), HRmax (maximal heart rate). RSH, repeated-sprint training in hypoxia; RSN, repeated-sprint training in normoxia. *Indicates differences with respect to baseline (post-hoc t-test with Bonferroni correction):
P < 0.05.